Is Seres Therapeutics Inc (MCRB) A Good Stock To Buy?

We already know that not all hedge funds are bullish on the stock and some hedge funds actually dumped their positions entirely. At the top of the heap, Roberto Mignone’s Bridger Management dumped the biggest stake of the 700 funds followed by Insider Monkey, valued at an estimated $18.1 million in stock, and Principal Global Investors’s Columbus Circle Investors was right behind this move, as the fund cut about $10.7 million worth of Seres Therapeutics Inc (NASDAQ:MCRB) shares.

Let’s also examine hedge fund activity in other stocks – not necessarily in the same industry as Seres Therapeutics Inc (NASDAQ:MCRB) but similarly valued. These stocks are NN, Inc. (NASDAQ:NNBR), First Financial Corp (NASDAQ:THFF), Alpha and Omega Semiconductor Ltd (NASDAQ:AOSL), and Movado Group, Inc (NYSE:MOV). This group of stocks’ market values are closest to MCRB’s market value.

As you can see these stocks had an average of 11 hedge funds with bullish positions and the average amount invested in these stocks was $39 million. That figure was $25 million in MCRB’s case. Movado Group, Inc (NYSE:MOV) is the most popular stock in this table. On the other hand First Financial Corp (NASDAQ:THFF) is the least popular one with only 5 bullish hedge fund positions. Seres Therapeutics Inc (NASDAQ:MCRB) is not the most popular stock in this group but hedge fund interest is still above average. This is a slightly positive signal but we’d rather spend our time researching stocks that hedge funds are piling on. In this regard MOV might be a better candidate to consider taking a long position in.

Suggested Articles:
Highest Paying States For ER Doctors
Most Affordable Architecture Schools
Most Infamous Cults And Cult Leaders

Disclosure: None